| Nadia N Cabrilo, MD | |
|
2860 Sw Mission Woods Dr, Topeka, KS 66614-5604 | |
| (785) 273-7571 | |
| Not Available |
| Full Name | Nadia N Cabrilo |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2860 Sw Mission Woods Dr, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295981041 | NPI | - | NPPES |
| 200637450H | Medicaid | KS | |
| KA2129025 | Other | KS | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 04-34113 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nadia N Cabrilo, MD 2860 Sw Mission Woods Dr, Topeka, KS 66614-5604 Ph: (785) 273-7571 | Nadia N Cabrilo, MD 2860 Sw Mission Woods Dr, Topeka, KS 66614-5604 Ph: (785) 273-7571 |
News Archive
In the first phase III study to include Western lung cancer patients, first-line treatment with erlotinib (Tarceva) nearly doubled progression-free survival compared with chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
Somaxon Pharmaceuticals, Inc. today announced that Somaxon and Procter & Gamble have entered into a co-promotion agreement for Silenor (doxepin), a newly-approved treatment for insomnia characterized by difficulty with sleep maintenance.
Vestagen Technical Textiles, Inc., today announced that it has entered into agreements with Scrubs AC, Inc., d/b/a allheart, to produce and distribute protective garments for the healthcare sector manufactured using Vestagen's Vestex® protective fabric.
A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).
› Verified 6 days ago
Dr. John Samuel Plowden Jr., MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 929 Sw Mulvane St, Topeka, KS 66606 Phone: 785-270-4100 Fax: 785-270-4202 | |
Tara Denise Pridgett, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Sw 6th Ave, Topeka, KS 66606 Phone: 785-235-0335 Fax: 785-235-0368 | |
James Lynn Casey, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-6241 Fax: 785-270-4343 | |
Ms. Teresa A Crowe, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Sw 6th Ave, Topeka, KS 66606 Phone: 785-235-0104 | |
Mildred Laura Murphy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Sw 10th Ave., Pediatric Intensive Care Unit, Topeka, KS 66604 Phone: 785-354-5242 | |
Antonio A Huaman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5242 Fax: 785-354-6349 | |
Dennis Michael Cooley, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Sw 6th Ave, Topeka, KS 66606 Phone: 785-235-0335 Fax: 785-235-0368 |